Carregant...
Cancer neoantigens as potential targets for immunotherapy
Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and programed cell death protein 1 (PD-1) or its ligand PD-L1 have increased the survival and cure rates for patients with many cancer types in various disease settings. However, only 10–40% of can...
Guardat en:
| Publicat a: | Clin Exp Metastasis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Netherlands
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097110/ https://ncbi.nlm.nih.gov/pubmed/33950415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-021-10091-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|